Showing results (11-20 of 3,350) with videos related to

Sort By:
Pageof 335
The Lancet. Oncology|October 23, 2010
Discontinuation of imatinib in patients with chronic myeloid leukaemia who have maintained complete molecular remission for at least 2 years: the prospective, multicentre Stop Imatinib (STIM) trialFrançois-Xavier Mahon, Delphine Réa, Joëlle Guilhot, et al.
The Lancet. Oncology|March 1, 2011
International Cognition and Cancer Task Force recommendations to harmonise studies of cognitive function in patients with cancerJeffrey S Wefel, Janette Vardy, Tim Ahles, et al.
The Lancet. Oncology|December 15, 2010
Risk of colorectal and endometrial cancers in EPCAM deletion-positive Lynch syndrome: a cohort studyMarlies J E Kempers, Roland P Kuiper, Charlotte W Ockeloen, et al.
The Lancet. Oncology|December 15, 2010
Sensitivity of transvaginal ultrasound screening for endometrial cancer in postmenopausal women: a case-control study within the UKCTOCS cohortIan Jacobs, Aleksandra Gentry-Maharaj, Matthew Burnell, et al.
The Lancet. Oncology|November 12, 2010
Microbial and viral pathogens in colorectal cancerDanielle Collins, Aisling M Hogan, Desmond C Winter
The Lancet. Oncology|November 13, 2010
Cetuximab, gemcitabine, and oxaliplatin in patients with unresectable advanced or metastatic biliary tract cancer: a phase 2 studyBirgit Gruenberger, Johannes Schueller, Ute Heubrandtner, et al.
The Lancet. Oncology|March 8, 2011
Zalutumumab plus best supportive care versus best supportive care alone in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck after failure of platinum-based chemotherapy: an open-label, randomised phase 3 trialJean-Pascal Machiels, Somasundaram Subramanian, Agnes Ruzsa, et al.
The Lancet. Oncology|February 26, 2011
Treatment implications of the emerging molecular classification system for melanomaEmanuela Romano, Gary K Schwartz, Paul B Chapman, et al.
The Lancet. Oncology|July 6, 2010
Intrathecal chemotherapy for treatment of leptomeningeal dissemination of metastatic tumoursPatrick Beauchesne
The Lancet. Oncology|July 24, 2010
Safety and efficacy of first-line bevacizumab-based therapy in advanced non-squamous non-small-cell lung cancer (SAiL, MO19390): a phase 4 studyLucio Crinò, Eric Dansin, Pilar Garrido, et al.
Pageof 335